IMCRNasdaq United Kingdom
Market cap
$1.635 B
$34.00 -1.45%
Close of 7 Aug 2026
Revenue
$400.0M
#2024 by revenue
Earnings
-$35.5M
Loss-making
Shares outstanding
51,498,617
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Immunocore are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.